Swiss National Bank’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Swiss National Bank’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-17,700	Closed	-$432K	–	2496
2017 Q4	$432K	Hold	17,700	–	–	﹤0.01%	2442
2017 Q3	$327K	Hold	17,700	–	–	﹤0.01%	2469
2017 Q2	$293K	Hold	17,700	–	–	﹤0.01%	2523
2017 Q1	$244K	Buy	17,700 +8,800	+99%	+$141K	﹤0.01%	2504
2016 Q4	$169K	Hold	8,900	–	–	﹤0.01%	2557
2016 Q3	$197K	Hold	8,900	–	–	﹤0.01%	2516
2016 Q2	$163K	Hold	8,900	–	–	﹤0.01%	2565
2016 Q1	$155K	Buy	8,900 +2,000	+29%	+$32.4K	﹤0.01%	2579
2015 Q4	$116K	Hold	6,900	–	–	﹤0.01%	2631
2015 Q3	$124K	Buy	6,900 +1,100	+19%	+$24.5K	﹤0.01%	2543
2015 Q2	$150K	Buy	+5,800	New	+$147K	﹤0.01%	2564

Swiss National Bank's ENTL Position: Q1 2018 in Review

Swiss National Bank sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 17,700 shares — an estimated $432K sold.

Swiss National Bank first reported a position in ENTL in Q2 2015 and held it in 11 quarters. The position peaked at $432K in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

Swiss National Bank reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Swiss National Bank sold 17,700 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $432K.
Swiss National Bank first reported a position in Entellus Medical, Inc. Common Stock in Q2 2015 and held it in 11 quarters.
Swiss National Bank's Entellus Medical, Inc. Common Stock position peaked at $432K in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Swiss National Bank's 13F filing for Q1 2018, filed 4 May 2018.